Literature DB >> 7809072

Identification of the TCL1 gene involved in T-cell malignancies.

L Virgilio1, M G Narducci, M Isobe, L G Billips, M D Cooper, C M Croce, G Russo.   

Abstract

The TCL1 locus on chromosome 14q32.1 is frequently involved in chromosomal translocations and inversions with one of the T-cell receptor loci in human T-cell leukemias and lymphomas. The chromosome 14 region translocated or rearranged involves approximately 350 kb of DNA at chromosome band 14q32.1. Within this region we have identified a gene coding for a 1.3-kb transcript, expressed only in restricted subsets of cells within the lymphoid lineage and expressed at high levels in leukemic cells carrying a t(14;14)(q11;q32) chromosome translocation or a inv(14)(q11;q32) chromosome inversion. The cognate cDNA sequence reveals an open reading frame of 342 nt encoding a protein of 14 kDa. The TCL1 gene sequence, which, to our knowledge, shows no sequence homology with other human genes, is preferentially expressed early in T- and B-lymphocyte differentiation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7809072      PMCID: PMC45472          DOI: 10.1073/pnas.91.26.12530

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Molecular analysis of a t(14;14) translocation in leukemic T-cells of an ataxia telangiectasia patient.

Authors:  G Russo; M Isobe; R Gatti; J Finan; O Batuman; K Huebner; P C Nowell; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

2.  Long-term growth of malignant thymocytes in vitro.

Authors:  S D Smith; P McFall; R Morgan; M Link; F Hecht; M Cleary; J Sklar
Journal:  Blood       Date:  1989-06       Impact factor: 22.113

3.  Variant translocation of the bcl-2 gene to immunoglobulin lambda light chain gene in chronic lymphocytic leukemia.

Authors:  M Adachi; J Cossman; D Longo; C M Croce; Y Tsujimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

4.  Role of chromosome translocations in human neoplasia.

Authors:  C M Croce
Journal:  Cell       Date:  1987-04-24       Impact factor: 41.582

Review 5.  Oncogene activation by chromosome translocation in human malignancy.

Authors:  F G Haluska; Y Tsujimoto; C M Croce
Journal:  Annu Rev Genet       Date:  1987       Impact factor: 16.830

6.  The breakpoint of an inversion of chromosome 14 in a T-cell leukemia: sequences downstream of the immunoglobulin heavy chain locus are implicated in tumorigenesis.

Authors:  R Baer; A Heppell; A M Taylor; P H Rabbitts; B Boullier; T H Rabbitts
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

7.  Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma.

Authors:  Y Tsujimoto; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

8.  Molecular analysis of a t(7;14)(q35;q32) chromosome translocation in a T cell leukemia of a patient with ataxia telangiectasia.

Authors:  G Russo; M Isobe; L Pegoraro; J Finan; P C Nowell; C M Croce
Journal:  Cell       Date:  1988-04-08       Impact factor: 41.582

9.  Cloning of the gene encoding the delta subunit of the human T-cell receptor reveals its physical organization within the alpha-subunit locus and its involvement in chromosome translocations in T-cell malignancy.

Authors:  M Isobe; G Russo; F G Haluska; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

10.  Human T-cell tumours containing chromosome 14 inversion or translocation with breakpoints proximal to immunoglobulin joining regions at 14q32.

Authors:  L Mengle-Gaw; H F Willard; C I Smith; L Hammarström; P Fischer; P Sherrington; G Lucas; P W Thompson; R Baer; T H Rabbitts
Journal:  EMBO J       Date:  1987-08       Impact factor: 11.598

View more
  54 in total

1.  TCL1 oncogene expression in AIDS-related lymphomas and lymphoid tissues.

Authors:  M Teitell; M A Damore; G G Sulur; D E Turner; M H Stern; J W Said; C T Denny; R Wall
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

2.  Molecular portraits of B cell lineage commitment.

Authors:  Markus Müschen; Sanggyu Lee; Guolin Zhou; Niklas Feldhahn; Varun Singh Barath; Jianjun Chen; Cordula Moers; Martin Krönke; Janet D Rowley; San Ming Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-15       Impact factor: 11.205

Review 3.  Molecular basis of CLL.

Authors:  Yuri Pekarsky; Nicola Zanesi; Carlo M Croce
Journal:  Semin Cancer Biol       Date:  2010-09-21       Impact factor: 15.707

4.  Tcl1 protein functions as an inhibitor of de novo DNA methylation in B-cell chronic lymphocytic leukemia (CLL).

Authors:  Alexey Palamarchuk; Pearlly S Yan; Nicola Zanesi; Linan Wang; Benjamin Rodrigues; Mark Murphy; Veronica Balatti; Arianna Bottoni; Natalya Nazaryan; Hansjuerg Alder; Laura Rassenti; Thomas J Kipps; Michael Freitas; Carlo M Croce; Yuri Pekarsky
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

5.  High-level DNA amplifications are common genetic aberrations in B-cell neoplasms.

Authors:  C A Werner; H Döhner; S Joos; L H Trümper; M Baudis; T F Barth; G Ott; P Möller; P Lichter; M Bentz
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

6.  Tcl1 interacts with Atm and enhances NF-κB activation in hematologic malignancies.

Authors:  Eugenio Gaudio; Riccardo Spizzo; Francesco Paduano; Zhenghua Luo; Alexey Efanov; Alexey Palamarchuk; Amanda S Leber; Mohamed Kaou; Nicola Zanesi; Arianna Bottoni; Stefan Costinean; Laura Z Rassenti; Tatsuya Nakamura; Thomas J Kipps; Rami I Aqeilan; Yuri Pekarsky; Francesco Trapasso; Carlo M Croce
Journal:  Blood       Date:  2011-11-07       Impact factor: 22.113

7.  Dysregulated TCL1 requires the germinal center and genome instability for mature B-cell transformation.

Authors:  Rhine R Shen; David O Ferguson; Mathilde Renard; Katrina K Hoyer; Unkyu Kim; Xingpei Hao; Frederick W Alt; Robert G Roeder; Herbert C Morse; Michael A Teitell
Journal:  Blood       Date:  2006-05-25       Impact factor: 22.113

8.  TORC2 regulates germinal center repression of the TCL1 oncoprotein to promote B cell development and inhibit transformation.

Authors:  Ali I Kuraishy; Samuel W French; Mara Sherman; Marco Herling; Dan Jones; Randolph Wall; Michael A Teitell
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-04       Impact factor: 11.205

9.  Peptide-mediated activation of Akt and extracellular regulated kinase signaling prevents lymphocyte apoptosis.

Authors:  Jonathan E McDunn; Jared T Muenzer; Latif Rachdi; Katherine C Chang; Chris G Davis; W Michael Dunne; David Piwnica-Worms; Ernesto Bernal-Mizrachi; Richard S Hotchkiss
Journal:  FASEB J       Date:  2007-09-13       Impact factor: 5.191

10.  CD5+CD23+ leukemic cell populations in TCL1 transgenic mice show significantly increased proliferation and Akt phosphorylation.

Authors:  A Efanov; N Zanesi; N Nazaryan; U Santanam; A Palamarchuk; C M Croce; Y Pekarsky
Journal:  Leukemia       Date:  2010-04-01       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.